Scientific Literature Review Several studies have investigated the side effects of semaglutide, including its potential impact on the heart
Others in its drug class like Wegovy, have also seen a surge in demand, one so high that the Food and Drug Administration has reported a national drug shortage for them
and Europe to approve and broadly adopt GLP-1 therapy, with Japanese prescribers known for their comfort with GLP-1 in T2DM management
For weight loss, FDA 2026 rules require a BMI of 30+, or 27+ with a health issue (like heart disease)
Weight Loss Memberships - R3 SlimSTAT Comprehensive monthly packages featuring semaglutide injections, prescription appetite suppressants, weekly consultations, and advanced body contouring technology to achieve optimal results